World Clinical Drug
|
2023, 44(10): 1090-1093
• Article •
Application of nafamostat mosilate in heparin induced thrombocytopenia: a case report and literature review
Full
Wei PANG, Qinmin GE*
Affiliations
- Department of Emergency Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
Published: 2023-10-10
doi: 10.13683/j.wph.2023.10.012
Outline
nafamostat mosilate
/
low molecular weight heparin
/
thrombocytopenia
/
continuous renal replacement therapy
庞韦, 葛勤敏.
1例甲磺酸萘莫司他在低分子肝素诱发血小板减少症应用并文献复习.
世界临床药物,
2023
, 44
(10)
: 1090
-1093
.
DOI: 10.13683/j.wph.2023.10.012
Wei PANG, Qinmin GE.
Application of nafamostat mosilate in heparin induced thrombocytopenia: a case report and literature review[J].
World Clinical Drug,
2023
, 44
(10)
: 1090
-1093
.
DOI: 10.13683/j.wph.2023.10.012
Year 2023 volume 44 Issue 10
16
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.10.012
- Receive Date:2022-07-24
- Online Date:2026-11-18
- Published:2023-10-10